CLC Bio Partners with Hoffmann-La Roche, Others on MDx Platform Using FFPE
September 08, 2010
CLC Bio Partners with Hoffmann-La Roche, Others on MDx Platform Using FFPE
The $5M project aims to develop a complete platform for selecting FFPE samples, choosing sequencing technology, and then assembling and analyzing the high-throughput sequencing data.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.